Figure 5 — A circadian rhythm-related biomarker for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma

Research Paper|Volume 14, Issue 23|pp. 9617–9631

A circadian rhythm-related biomarker for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma

100%

Figure 5.Functional analysis. (A, B) Gene oncology analysis showed that multiple cancer-associated pathways were identified. (C, D) GSEA showed multiple cancer-associated pathways were significantly enriched in the high-risk patients.